WNK2 and prostate cancer: Consistent with the stunted growth of the sh-St1 cells, we have previously shown that STAMP1 knockdown in human prostate cancer cells decreases proliferation by deregulating cell cycle related protein expression and activation of the mitogen-activated protein kinase (MAPK) pathway [35].